Based on these findings, it is concluded that curcumin derivatives have a strong inhibitory potential against VEGFR1, VEGFR3, VEGFR2 and the ERBB protein, and that they can be used to treat cancer and its associated malignancies. The gene discussed is FLT4; the disease is cancer.